Geographic variation in heart failure with mildly reduced or preserved ejection fraction: the FINEARTS-HF trial

Back

HFA Premium Access

Geographic variation in heart failure with mildly reduced or preserved ejection fraction: the FINEARTS-HF trial

Session: Exploring physiological and regional variations in HFpEF

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Speaker: Doctor M. Vaduganathan (Boston, US)

Event: Heart Failure 2025

Congress Presentation

Add to my library

About the speaker

Doctor Muthiah Vaduganathan

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)

36 presentations

11 followers

5 more presentations in this session

Effect of dapagliflozin on ventilatory control during low-intensity exercise in heart failure with preserved ejection fraction

Speaker: Doctor S. Doi (Kawasaki, JP)

Superiority of the HFA-PEFF score over the H2FPEF score in detecting pulmonary hypertension related to left heart disease with and without elevated pulmonary artery wedge pressure

Speaker: Doctor F. Bauer (Le Kremlin-Bicetre, FR)

Renal denervation for resistant hypertension in aortic coarctation: long-term impact on HFpEF risk and diastolic function

Speaker: Doctor P. Sagmeister (Leipzig, DE)

The reversal of the beneficial effects of the sauna intervention on exercise capacity in patients with HFpEF within a 3-month period. Real-time data collected using wearable technology

Speaker: Associate Professor T. Bekfani (Magdeburg, DE)

Sex-specific performance of HFpEF diagnostic algorithms across two independent cohorts

Speaker: Doctor A. Achten (Maastricht, NL)

Access the full session

Exploring physiological and regional variations in HFpEF

Speakers: Doctor M. Vaduganathan, Doctor S. Doi, Doctor F. Bauer, Doctor P. Sagmeister, Associate Professor T. Bekfani...

Access

About the event

Heart Failure 2025

17 May - 20 May 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources